Study Description

Discovery of resistance mechanisms to the BRAF inhibitor vemurafenib in metastatic BRAF mutant melanoma by massively-parallel sequencing of tumour... Show More

Study Accession Alternative Stable ID type
EGAS00001000551 Other

Publications